Your browser doesn't support javascript.
loading
Enantioselective Organophotocatalytic Telescoped Synthesis of a Chiral Privileged Active Pharmaceutical Ingredient.
Herbrik, Fabian; Sanz, Miguel; Puglisi, Alessandra; Rossi, Sergio; Benaglia, Maurizio.
Afiliação
  • Herbrik F; Dipartimento di Chimica, Università degli Studi di Milano, Via Camillo Golgi 19, 20133, Milano, Italy.
  • Sanz M; Taros Chemicals GmbH & Co. KG, Emil-Figge-Strasse 76 A, 44227, Dortmund, Germany.
  • Puglisi A; Dipartimento di Chimica, Università degli Studi di Milano, Via Camillo Golgi 19, 20133, Milano, Italy.
  • Rossi S; Dipartimento di Chimica, Università degli Studi di Milano, Via Camillo Golgi 19, 20133, Milano, Italy.
  • Benaglia M; Dipartimento di Chimica, Università degli Studi di Milano, Via Camillo Golgi 19, 20133, Milano, Italy.
Chemistry ; 28(33): e202200164, 2022 Jun 10.
Article em En | MEDLINE | ID: mdl-35239197
The continuous flow, enantioselective, organophotoredox catalytic asymmetric alkylation of aldehydes was studied, by using a homemade, custom-designed photoreactor for reactions under cryogenic conditions. Going from microfluidic conditions up to a 10 mL mesofluidic reactor, an increase of productivity by almost 18000 % compared to the batch reaction was demonstrated. Finally, for the first time, a stereoselective photoredox organocatalytic continuous flow reaction in a fully telescoped process for an active pharmaceutical ingredient (API)synthesis was successfully achieved. The final process consists of four units of operation: visible light-driven asymmetric catalytic benzylation under continuous flow, inline continuous work-up, neutralisation and a final oxidative amidation step afforded the pharmaceutically active molecule in 95 % e.e.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article